Treatment outcomes of retreated patients with isoniazid/rifampicin resistant pulmonary tuberculosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Treatment outcomes of retreated patients with isoniazid/rifampicin resistant pulmonary tuberculosis ; volume:24 ; number:1 ; day:2 ; month:1 ; year:2024 ; pages:1-8 ; date:12.2024
BMC infectious diseases ; 24, Heft 1 (2.1.2024), 1-8, 12.2024
- Urheber
-
Zhang, Lijie
Han, Xiqin
Ge, Qiping
Shu, Wei
Sun, Yuxian
Gao, Jingtao
Xie, Shiheng
Wang, Jingping
Gao, Weiwei
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12879-023-08909-2
- URN
-
urn:nbn:de:101:1-2024031409292597815130
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zhang, Lijie
- Han, Xiqin
- Ge, Qiping
- Shu, Wei
- Sun, Yuxian
- Gao, Jingtao
- Xie, Shiheng
- Wang, Jingping
- Gao, Weiwei
- SpringerLink (Online service)
Ähnliche Objekte (12)
Treatment of isoniazid-resistant pulmonary tuberculosis
Airway microecology in rifampicin-resistant and rifampicin-sensitive pulmonary tuberculosis patients
Risk factors of adult isoniazid-resistant and rifampicin-susceptible tuberculosis in Nanjing, 2019–2021
Correction: Risk factors of adult isoniazid-resistant and rifampicin-susceptible tuberculosis in Nanjing, 2019–2021
Could high-concentration rifampicin kill rifampicin-resistant M. tuberculosis? Rifampicin MIC test in rifampicin-resistant isolates from patients with osteoarticular tuberculosis
Genotypic detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis strains by DNA sequencing: a randomized trial
ErratumTo: Genotypic detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis strains by DNA sequencing: a randomized trial
Can resistance to either isoniazid or rifampicin predict multidrug resistance tuberculosis (MDR-TB)
Sex-dependent variability of isoniazid and rifampicin serum levels in patients with tuberculosis
Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic
Characteristics of rifampicin-resistant tuberculosis detection in China, 2015–2019
Evaluation of Anyplex™ II MTB/MDR kit’s performance to rapidly detect isoniazid and rifampicin resistant Mycobacterium tuberculosis from various clinical specimens
Treatment of isoniazid-resistant pulmonary tuberculosis
Airway microecology in rifampicin-resistant and rifampicin-sensitive pulmonary tuberculosis patients
Risk factors of adult isoniazid-resistant and rifampicin-susceptible tuberculosis in Nanjing, 2019–2021
Correction: Risk factors of adult isoniazid-resistant and rifampicin-susceptible tuberculosis in Nanjing, 2019–2021
Could high-concentration rifampicin kill rifampicin-resistant M. tuberculosis? Rifampicin MIC test in rifampicin-resistant isolates from patients with osteoarticular tuberculosis
Genotypic detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis strains by DNA sequencing: a randomized trial
ErratumTo: Genotypic detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis strains by DNA sequencing: a randomized trial
Can resistance to either isoniazid or rifampicin predict multidrug resistance tuberculosis (MDR-TB)
Sex-dependent variability of isoniazid and rifampicin serum levels in patients with tuberculosis
Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic
Characteristics of rifampicin-resistant tuberculosis detection in China, 2015–2019
Evaluation of Anyplex™ II MTB/MDR kit’s performance to rapidly detect isoniazid and rifampicin resistant Mycobacterium tuberculosis from various clinical specimens
Treatment of isoniazid-resistant pulmonary tuberculosis
Airway microecology in rifampicin-resistant and rifampicin-sensitive pulmonary tuberculosis patients
Risk factors of adult isoniazid-resistant and rifampicin-susceptible tuberculosis in Nanjing, 2019–2021
Correction: Risk factors of adult isoniazid-resistant and rifampicin-susceptible tuberculosis in Nanjing, 2019–2021
Could high-concentration rifampicin kill rifampicin-resistant M. tuberculosis? Rifampicin MIC test in rifampicin-resistant isolates from patients with osteoarticular tuberculosis
Genotypic detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis strains by DNA sequencing: a randomized trial
ErratumTo: Genotypic detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis strains by DNA sequencing: a randomized trial
Can resistance to either isoniazid or rifampicin predict multidrug resistance tuberculosis (MDR-TB)
Sex-dependent variability of isoniazid and rifampicin serum levels in patients with tuberculosis
Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic
Characteristics of rifampicin-resistant tuberculosis detection in China, 2015–2019